Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07569510Completed
—
Impact of Pelvic Asymmetry on Hip Joint ProprioceptionNoura ahmed ibrahim hendy
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
NCT07570264
LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory TrialNunaps IncRecruitingNot Applicable
NCT07570264Recruiting
Not Applicable
LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory Tr...Nunaps Inc
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07569575
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone FracturesHuaMg Perfection Med Tech (Suzhou) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07569575Not Yet Recruiting
Not Applicable
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone FracturesHuaMg Perfection Med Tech...
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07571070
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur BoxersFederal University of VicosaCompletedNot Applicable
NCT07571070Completed
Not Applicable
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Ama...Federal University of Vic...
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570082
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals Inc.RecruitingPhase 1
NCT07570082Recruiting
Phase 1
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals...
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07571928
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive AzoospermiaMartin Blomberg JensenNot Yet RecruitingPhase 1
NCT07571928Not Yet Recruiting
Phase 1
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoo...Martin Blomberg Jensen
NCT07569861
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeUniversity Hospital, Basel, SwitzerlandNot Yet RecruitingNot Applicable
NCT07569861Not Yet Recruiting
Not Applicable
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of P...University Hospital, Base...
NCT07571798
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sacroiliac Screw Insertion in High Energy Posterior Pelvic Ring Injured PatientsChonburi hospitalActive Not RecruitingNot Applicable
NCT07571798Active Not Recruiting
Not Applicable
The Difference of Two and Three Fluoroscopic Views of Sacrum for Percutaneous Sa...Chonburi hospital
NCT07571837
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical TrialAl-Azhar UniversityRecruitingNot Applicable
NCT07571837Recruiting
Not Applicable
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication...Al-Azhar University
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed2 (10%)
Active, not recruiting2 (10%)
not_applicable10 (50%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 13 (15%)
Phase 41 (5%)